Professional Documents
Culture Documents
2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd. | JDDG | 1610-0379/2015/1303
203
Review Article Microbiological diagnostics in chronic wounds
These components are collectively referred to as preanaly- are considered to be of great significance. Although these re-
sis. In keeping with current guidelines on laboratory tests commendations call for wound swabs in the screening for
(Rili-BK) issued by the German Medical Association, the MRPs, they do not elaborate on sampling techniques or any
physician who orders the respective test is also responsible further details as to practical implementation [5]. For examp-
for any preanalytic steps. Only after the specimen has rea- le, the results of MRSA-specific PCR may already be availab-
ched the laboratory is the responsibility for the sample and its le after a few hours, however, they usually show only typical
correct processing (for example, choice and quality of culture segments of the S. aureus genome and the mecA gene.
media, analysis and identification of bacteria, reporting with
differentiation and semi-quantitative amounts, antibiogram/ Preanalysis in wound swabs
resistogram) transferred to the lab. The Rili-BK has legal
character and also describes various quality controls appli- First, it has to be determined whether a swab or a biopsy is
cable to laboratories. best suited for bacteriologic detection. The physician must
There are no legally binding regulations on performing clinically differentiate whether the microbiology workup is
microbiologic diagnostics. Recommendations by professio- done in the context of multiresistant pathogen screening, or
nal societies, such as guidelines published by the Association whether there are clinical signs of a wound infection requi-
of the Scientific Medical Societies in Germany (AWMF), and ring systemic antibiotic therapy [1, 6]. Initial tests for mul-
quality recommendations put forth by the German Society tiresistant pathogens are frequently only aimed at detecting
for Hygiene and Microbiology (DGHM), which primarily bacterial colonization; hence, the results are generally of no
apply to microbiology laboratories, may be used for reference consequence for any subsequent wound therapy. If the tests
[3, 4]. are positive for MRPs, specific hygienic and work protection
In case of a legal dispute, it is the medical experts job measures apply, which appear in the TRBA 250 [7] and the
to determine whether the preanalysis and the spectrum of June 2014 recommendations on MRSA by the Commission
ordered tests were appropriate to meet the objective, namely, for Hospital Hygiene and Infection Prevention (KRINKO) at
detection of a given infectious pathogen. This also includes the Robert Koch Institute (RKI) [5].
quickly relaying test results to treating physicians. Yet, hospi- The choice of preanalysis technique also depends on
tals continue to have deficits in this field, for example, when the intended diagnostic test. For PCR testing, transporting
initial samples are taken at the outpatient department and the swab in a gel matrix is not necessary, whereas such a gel
the patient is then admitted to the hospital; or, when a patient matrix should be used, if cultural detection is sought at an
has been discharged, and results are not always sent to the off-site lab (Table 1) (Figure 1).
follow-up facility in a timely fashion. If the patient sustains
any damages due to delayed treatment, the responsible par- Swab preparation
ties may be liable.
According to 23 section 3 of the German Protection There is no sufficient evidence as to the necessity for wound
against Infection Act, the recommendations of the Commissi- cleansing prior to wound swabbing (for example, using ste-
on for Hospital Hygiene and Infection Prevention (KRINKO) rile 0.9 % saline solution). Taking the KRINKO concept of
Swab Biopsy/excision
Sample container Swab with gel matrix Sterile tube with a drop of sterile distilled
For PCR without gel matrix water or physiological saline solution
Storage Optional: refrigerate to maintain Optional: refrigerate (28 C)
pathogen ratio, but loss of anaerobes
Test order Note: Screening for MRSA, MRGN, or Note: mycobacteria, actinomycetes,
other pathogenic bacteria Nocardia, other pathogenic bacteria,
Information given to the lab Prior antibiotic therapy Prior antibiotic therapy
Presumed contamination during Presumed contamination during biopsy
swabbing
204 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd. | JDDG | 1610-0379/2015/1303
Review Article Microbiological diagnostics in chronic wounds
2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd. | JDDG | 1610-0379/2015/1303
205
Review Article Microbiological diagnostics in chronic wounds
206 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd. | JDDG | 1610-0379/2015/1303
Review Article Microbiological diagnostics in chronic wounds
S1 guidelines of the task force on hygiene in hospitals deep infections of the skin, mucous membranes and soft tissu-
and private doctors offices of the AWMF working es, abscesses, osteomyelitis, and fistulas. Here, various utensils,
group: chronic wounds and those healing by secondary such as sterile swabs or a sterile sharp spoon, are listed without
intention hygiene requirements [4]. elaborating on their diagnostic value. As to the procedure, it
S3 guidelines of the German Society for Angiology So- is recommended to take a swab from the depth of the wound
ciety for Vascular Medicine: guidelines on the diagnosis after removing any coating. In chronic wounds, material may
and treatment of peripheral arterial occlusive disease also be obtained from the wound margins using a sharp spoon
(PAOD) [23]. [3]. In the section on wound infections in the guidelines of
the German Society for Pediatric Surgery, the point on thera-
Discussion py is followed simply by the word wound swab without any
further details on implementation or preparations. Given that
In the context of modern, guideline-based treatment of chro- this is followed by the removal of necrotic areas plus , one
nic wound patients, microbiologic aspects also have to be ta- may assume that, in case of clinical suspicion of a wound infec-
ken into account [24, 25]. However, a review of the current tion, a bacteriologic swab is to be taken prior to the removal of
literature shows it is still impossible to issue unequivocal, necrotic areas and additional measures,. Later, wound smears
evidence-based recommendations on the practical implemen- are again discussed in a section on special types: primarily in-
tation of bacteriologic diagnostics in these patients. The fol- fected wounds (bite/gun shot wounds) [21]. In the NVL on pre-
lowing is therefore aimed at critically discussing various re- ventive and therapeutic strategies for foot complications, deep
levant aspects and summarizing their clinical consequences. tissue samples are advised (at least) in type 2 diabetes patients
The section on wound infections In the DGP guidelines with such lesions. Sampling should be performed after mecha-
recommends bacteriologic swabs whenever a mixed infection is nical wound cleansing. As this information is listed under an-
suspected or response to initial therapy has been poor. Yet, this tibiotic therapy, it is safe to assume that this recommendation
particular procedure seems to be geared towards the clinical applies to cases with clinically suspected wound infections, and
suspicion of erysipelas. For venous leg ulcers, it is clearly stated the procedure should be carried out prior to administering sys-
that culturing biopsy tissue offers no advantage over taking a temic antibiotics [22].
swab in regard to microbiologic results [19]. The DGfW guide- Based on the current literature, superficial bacteriologic
lines, which primarily focus on wound treatment aspects, con- swabs are a sufficient screening method in patients with chro-
tain a statement on bacteriologic swabs only in the section on nic wounds, and should be done without prior cleansing. In
wound cleansing using medicinal larvae [20]. In the guidelines most cases, swabs are taken to rule out MRPs. While detecti-
of the task force hygiene in hospitals and private doctors of- on usually does not alter treatment, it does necessitate specific
fices, indications for bacterial workup include superficial and hygiene measures when treating these patients [5, 6, 26, 27].
2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd. | JDDG | 1610-0379/2015/1303
207
Review Article Microbiological diagnostics in chronic wounds
208 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd. | JDDG | 1610-0379/2015/1303
Review Article Microbiological diagnostics in chronic wounds
18 Kempf W, Flaig MJ, Kutzner H. Molecular diagnostics in infec- 24 Dissemond J, Augustin M, Eming SA et al. Modern wound care
tious skin diseases. J Dtsch Dermatol Ges 2013; 11(Suppl. 4): practical aspects of non-interventional topical treatment of
508. patients with chronic wounds. J Dtsch Dermatol Ges 2014; 12:
19 AWMF, S3-Leitlinie der Deutschen Gesellschaft fr Phlebolo- 54154.
gie: Diagnostik und Therapie des Ulcus cruris venosum. 25 Klein S, Schreml S, Dolderer J et al. Evidence-based topical
20 AWMF, S3-Leitlinie der Deutschen Gesellschaft fr Wundhei- management of chronic wounds according to the T.I.M.E.
lung und Wundbehandlung (DGfW): Lokaltherapie chronisch- principle. J Dtsch Dermatol Ges 2013; 11: 81929.
er Wunden bei Patienten mit den Risiken periphere arterielle 26 Jockenhfer F, Gollnick H, Herberger K et al. Aktuelle
Verschlusskrankheit, Diabetes mellitus, chronische vense Nachweisraten multiresistenter gramnegativer Bakterien
Insuffizienz. (3MRGN, 4MRGN) bei Patienten mit chronischem Ulcus cruris.
21 AWMF, S1-Leitlinie der Deutschen Gesellschaft fr Kinder- Hautarzt [im Druck].
chirurgie: Wunden und Wundbehandlung. 27 Jockenhfer F, Gollnick H, Herberger K et al. Bacteriological
22 AWMF, Nationale Versorgungsleitlinie (NVL) Typ- pathogen spectrum of chronic leg ulcers: Results of a multi-
2-Diabetes: Prventions- und Behandlungsstrategien fr center trial in dermatologic wound care centers differentiated
Fukomplikationen. by regions. J Dtsch Dermatol Ges 2013; 11: 105763.
23 AWMF, S3-Leitlinie der Deutschen Gesellschaft fr Angiolo- 28 Schwarzkopf A, Assenheimer B, Bltemann A et al. Hygiene-
gie Gesellschaft fr Gefmedizin: Leitlinien zur Diagnostik fachliche und rechtliche Bewertung der Anwendung von
und Therapie der peripheren arteriellen Verschlusskrankheit Leitungswasser als Wundsplung. Wundmanagement 2012; 6:
(PAVK). 1957.
2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd. | JDDG | 1610-0379/2015/1303
209